Study of BLU-808 in Healthy Adult Participants

Clinical trial NCT06948032 · COMPLETED

Trial details

NCT number: NCT06948032
Sponsor: Blueprint Medicines Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2024-08-07
Primary completion: 2025-01-21
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.